NCT06706700View on ClinicalTrials.gov

Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

RecruitingOBSERVATIONAL

Enrollment

586

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions

Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Cyst

Trial Locations (1)

20132

RECRUITING

San Raffaele Hospital, Milan

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER